EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 382 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $481,290 | +37.5% | 22,027 | +20.3% | 0.00% | +100.0% |
| Q2 2023 | $350,019 | -37.8% | 18,316 | -36.9% | 0.00% | -50.0% |
| Q1 2023 | $563,104 | -30.7% | 29,011 | -42.7% | 0.00% | -50.0% |
| Q4 2022 | $812,378 | +150.7% | 50,647 | +145.0% | 0.00% | +100.0% |
| Q3 2022 | $324,000 | -24.7% | 20,669 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $430,000 | -8.3% | 20,669 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $469,000 | -17.7% | 20,669 | -27.2% | 0.00% | -33.3% |
| Q4 2020 | $570,000 | +12.0% | 28,377 | +36.3% | 0.00% | 0.0% |
| Q3 2020 | $509,000 | -22.6% | 20,820 | -24.9% | 0.00% | -25.0% |
| Q2 2020 | $658,000 | +6.0% | 27,728 | -23.2% | 0.00% | -20.0% |
| Q1 2020 | $621,000 | +96.5% | 36,084 | +143.8% | 0.01% | +150.0% |
| Q2 2019 | $316,000 | -12.7% | 14,803 | -2.7% | 0.00% | 0.0% |
| Q1 2019 | $362,000 | – | 15,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |